A review on potential of PARP inhibitors in the treatment of prostate cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Egile nagusia: | Islam, Saidul |
|---|---|
| Beste egile batzuk: | Sharmin, Shahana |
| Formatua: | Thesis |
| Hizkuntza: | English |
| Argitaratua: |
Brac University
2022
|
| Gaiak: | |
| Sarrera elektronikoa: | http://hdl.handle.net/10361/17308 |
Antzeko izenburuak
-
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
nork: Karim, Azrin
Argitaratua: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
nork: Flora, Sanzida Alam
Argitaratua: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
nork: Meem, Manila
Argitaratua: (2023) -
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
nork: Alam, Tahera
Argitaratua: (2024) -
RIPK pathway, as a potential target, for cancer treatment - a review
nork: Jahan, Nusrat
Argitaratua: (2024)